149 related articles for article (PubMed ID: 26301967)
21. Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.
Brioli A; Perrone G; Patriarca F; Pezzi A; Nobile F; Ballerini F; Motta MR; Ronconi S; Tacchetti P; Catalano L; Zannetti BA; Rizzi S; Volpe S; Zamagni E; Liberati AM; Mancuso K; Boccadoro M; Davies FE; Morgan GJ; Palumbo A; Cavo M
Bone Marrow Transplant; 2015 May; 50(5):673-8. PubMed ID: 25642764
[TBL] [Abstract][Full Text] [Related]
22. Current status of art mobilization in Myeloma.
Sevindik OG; Korkmaz S; Altuntas F
Transfus Apher Sci; 2017 Dec; 56(6):850-853. PubMed ID: 29174798
[TBL] [Abstract][Full Text] [Related]
23. Blood graft cellular composition and posttransplant outcomes in myeloma patients mobilized with or without low-dose cyclophosphamide: a randomized comparison.
Valtola J; Silvennoinen R; Ropponen A; Siitonen T; Säily M; Sankelo M; Terävä V; Putkonen M; Kuittinen T; Pelkonen J; Mäntymaa P; Remes K; Varmavuo V; Jantunen E
Transfusion; 2016 Jun; 56(6):1394-401. PubMed ID: 27041692
[TBL] [Abstract][Full Text] [Related]
24. Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
Alegre A; Díaz-Mediavilla J; San-Miguel J; Martínez R; García Laraña J; Sureda A; Lahuerta JJ; Morales D; Bladé J; Caballero D; De la Rubia J; Escudero A; Díez-Martín JL; Hernández-Navarro F; Rifón J; Odriozola J; Brunet S; De la Serna J; Besalduch J; Vidal MJ; Solano C; Leon A; Sánchez JJ; Martínez-Chamorro C; Fernández-Rañada JM
Bone Marrow Transplant; 1998 Jan; 21(2):133-40. PubMed ID: 9489629
[TBL] [Abstract][Full Text] [Related]
25. Comparable engraftment kinetics following peripheral-blood stem-cell infusion mobilized with granulocyte colony-stimulating factor with or without cyclophosphamide in multiple myeloma.
Desikan KR; Barlogie B; Jagannath S; Vesole DH; Siegel D; Fassas A; Munshi N; Singhal S; Mehta J; Tindle S; Nelson J; Bracy D; Mattox S; Tricot G
J Clin Oncol; 1998 Apr; 16(4):1547-53. PubMed ID: 9552064
[TBL] [Abstract][Full Text] [Related]
26. Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization.
Vela-Ojeda J; Tripp-Villanueva F; Montiel-Cervantes L; Sánchez-Cortés E; Ayala-Sánchez M; Guevara-Moreno ME; García-León LD; Rosas-Cabral A; Esparza MA; González-Llaven J
Bone Marrow Transplant; 2000 Jun; 25(11):1141-6. PubMed ID: 10849526
[TBL] [Abstract][Full Text] [Related]
27. Stem cell mobilization in patients with dialysis-dependent multiple myeloma: Report of the Polish Myeloma Study Group.
Waszczuk-Gajda A; Drozd-Sokołowska J; Boguradzki P; Dybko J; Wróbel T; Basak GW; Mądry K; Snarski E; Charliński G; Frączak E; Matuszkiewicz-Rowińska J; Klinger M; Augustyniak-Bartosik H; Krajewska M; Żebrowski P; Król M; Urbanowska E; Jurczyszyn A; Taszner M; Jędrzejczak WW; Dwilewicz-Trojaczek J
J Clin Apher; 2018 Jun; 33(3):249-258. PubMed ID: 28922455
[TBL] [Abstract][Full Text] [Related]
28. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
[TBL] [Abstract][Full Text] [Related]
29. Advanced lytic lesion is a poor mobilization factor in peripheral blood stem cell collection in patients with multiple myeloma.
Jung SH; Yang DH; Ahn JS; Kim YK; Kim HJ; Lee JJ
J Clin Apher; 2014 Dec; 29(6):305-10. PubMed ID: 24764270
[TBL] [Abstract][Full Text] [Related]
30. Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.
Wuchter P; Ran D; Bruckner T; Schmitt T; Witzens-Harig M; Neben K; Goldschmidt H; Ho AD
Biol Blood Marrow Transplant; 2010 Apr; 16(4):490-9. PubMed ID: 19925876
[TBL] [Abstract][Full Text] [Related]
31. Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy.
Tricot G; Barlogie B; Zangari M; van Rhee F; Hoering A; Szymonifka J; Cottler-Fox M
Haematologica; 2008 Nov; 93(11):1739-42. PubMed ID: 18728024
[TBL] [Abstract][Full Text] [Related]
32. Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
Jacobs RW; Saliba RM; Sasaki K; Farhan S; Armas A; Shah ND; Bashir Q; Qureshi S; Rondon G; Hosing C; Popat U; Parmar S; Shah JJ; Wang M; Weber DM; Thomas SK; Orlowski RZ; Champlin RE; Qazilbash MH
Clin Lymphoma Myeloma Leuk; 2016 Jan; 16(1):36-42. PubMed ID: 26702475
[TBL] [Abstract][Full Text] [Related]
33. Autograft cellular composition and outcome in myeloma patients: Results of the prospective multicenter GOA study.
Turunen A; Silvennoinen R; Partanen A; Valtola J; Siitonen T; Putkonen M; Sankelo M; Pyörälä M; Kuittinen T; Penttilä K; Sikiö A; Savolainen ER; Mäntymaa P; Pelkonen J; Varmavuo V; Jantunen E
Transfusion; 2021 Jun; 61(6):1830-1844. PubMed ID: 33955591
[TBL] [Abstract][Full Text] [Related]
34. Collection of more hematopoietic progenitor cells with large volume leukapheresis in patients with multiple myeloma.
Desikan KR; Jagannath S; Siegel D; Nelson J; Bracy D; Barlogie B; Tricot G
Leuk Lymphoma; 1998 Feb; 28(5-6):501-8. PubMed ID: 9613979
[TBL] [Abstract][Full Text] [Related]
35. Comparison of engraftment following different stem cell mobilization modalities in patients with multiple myeloma treated with a uniform induction regimen containing bortezomib, cyclophosphamide and dexamethasone.
Benyamini N; Avivi I; Dann EJ; Zuckerman T; Lavi N; Katz T
Ann Hematol; 2017 Mar; 96(3):461-467. PubMed ID: 28013359
[TBL] [Abstract][Full Text] [Related]
36. Factors affecting stem cell mobilization for autologous hematopoietic stem cell transplantation.
Ozkurt ZN; Yegin ZA; Suyani E; Aki SZ; Acar K; Yagci M; Sucak GT
J Clin Apher; 2010; 25(5):280-6. PubMed ID: 20623783
[TBL] [Abstract][Full Text] [Related]
37. Current strategies for the management of autologous peripheral blood stem cell mobilization failures in patients with multiple myeloma.
Sahin U; Demirer T
J Clin Apher; 2018 Jun; 33(3):357-370. PubMed ID: 28980709
[TBL] [Abstract][Full Text] [Related]
38. Delayed stem cell transplantation for the management of relapsed or refractory multiple myeloma.
Gertz MA; Lacy MQ; Inwards DJ; Gastineau DA; Tefferi A; Chen MG; Witzig TE; Greipp PR; Litzow MR
Bone Marrow Transplant; 2000 Jul; 26(1):45-50. PubMed ID: 10918404
[TBL] [Abstract][Full Text] [Related]
39. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
[TBL] [Abstract][Full Text] [Related]
40. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
